Loading...
Loading...
RXST| Name | Value |
|---|---|
| Revenues | 40.2M |
| Cost of Revenue | 11.4M |
| Gross Profit | 28.8M |
| Operating Expense | 37.4M |
| Operating I/L | -8.6M |
| Other Income/Expense | 2.7M |
| Interest Income | 2.7M |
| Pretax | -5.9M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -5.9M |
RxSight, Inc. is a medical technology company specializing in light adjustable intraocular lenses (LAL) for cataract surgery. Its flagship product, the RxSight system, allows doctors to customize and enhance visual acuity for patients post-surgery. The system comprises the RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed. This technology enables cataract doctors to offer personalized vision correction, providing a unique value proposition in the cataract surgery market.
